Lateral Flow Device for CSF Leak Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing cerebrospinal fluid (CSF) leaks during spinal surgery are inefficient, requiring lengthy laboratory analysis and skilled professionals, making it difficult to achieve rapid and accurate detection, especially in post-operative settings where timely intervention is critical.
Innovation Solution
A lateral flow device utilizing transferrin-binding antibodies and sialic acid-specific lectin for selective detection of asialo-transferrin, enabling rapid and sensitive identification of CSF leaks directly from biological samples, allowing for immediate surgical intervention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If electrophoresis is used to detect β2TF, then detection precision is improved, but analysis time increases significantly
Solution Approach 1:
The patent replaces the electrophoresis-based mechanical separation system with an immunoassay system using antibodies and lectins. The lateral flow device uses antibody-antigen binding and lectin-carbohydrate binding to detect β2TF, eliminating the need for electrical fields and gel matrices, thereby reducing analysis time while maintaining detection precision
Solution Approach 2:
The patent changes the detection parameters from electrophoretic mobility separation to immunological and biochemical binding reactions. By using specific antibodies against transferrin and sialic acid-specific lectins, the system achieves rapid detection through binding affinity rather than physical separation, significantly reducing analysis time
2Measurement precision
If electrophoresis-based assay is performed in specialized laboratories, then detection precision is improved, but device complexity and operational difficulty increase
Solution Approach 1:
The patent extracts the essential detection function from the complex laboratory electrophoresis system and consolidates it into a simplified lateral flow device. By taking out only the necessary components (antibodies, lectins, and detection elements) and removing unnecessary infrastructure (electrophoresis tanks, power supplies, skilled operators), the system achieves high precision with minimal device complexity
Solution Approach 2:
The patent employs disposable lateral flow strips that integrate all necessary reagents (antibodies, lectins, detection particles) into a single-use format. This eliminates the need for expensive, complex, reusable laboratory equipment and reduces operational complexity, allowing non-specialized personnel to perform accurate detections
3Measurement precision
If conventional electrophoresis is used for CSF leak detection, then diagnostic accuracy is improved, but turnaround time increases
Solution Approach 1:
The patent performs preliminary action by pre-coating the lateral flow strip with specific antibodies and lectins before use. This pre-preparation allows the actual detection to proceed rapidly when the sample is applied, as the binding components are already in place and ready to react, significantly reducing turnaround time while maintaining diagnostic accuracy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high specificity (97.1%) and sensitivity (96.2%) in detecting CSF leaks, facilitating timely surgical decisions and reducing the risk of complications such as meningitis.
Implementation Method 1
a lateral flow device utilizing transferrin-binding antibodies and sialic acid-specific lectin for selective detection of asialo-transferrin
Implementation Method 2
a lateral flow device utilizing transferrin-binding antibodies and sialic acid-specific lectin for selective detection of asialo-transferrin
Data Source
AI summary
The invention encompasses methods and test strips for detecting the presence of cerebrospinal fluid (CSF) in a biological sample comprising removing sialo-transferrin and selectively detecting or measuring asialo-transferrin in the biological sample.